|
国际皮肤性病学杂志 2002 28 (4): 231-233 ISSN: 2096-5540 CN: 32-1880/R |
|
|
|
|
|
黑素细胞在白癜风中的免疫损伤 |
何怡, 郑志忠 |
复旦大学附属华山医院皮肤科 上海 200040 |
收稿日期 2001-11-01 修回日期 null 网络版发布日期 null |
参考文献 [1] Kovacs SO.Vitiligo.J Am Acad Dermatol,1998,38(5 Pt 1):647-666. [2] Nishimura EK,Yoshida H,Kunisada T,et al.Regulation of E-and P-cadherin expression correlated with melanocyte migration and diversification.Dev Biol,1999,215(2):155-166. [3] Ardic FN,Aktan S,Kara CO,et al.High-frequency hearing and reflex latency in patients with pigment disorder.Am J Otolaryngol,1998,19(6):365-369. [4] Kobayashi N,Nakagawa A,Muramatsu T,et al.Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis.J Invest Dermatol,1998,110(5):806-810. [5] Lim HW,Cooper K.The health impact of solar radiation and prevention strategies:Report of the Environment Council,American Academy of Dermatology.J Am Acad Dermatol,1999,41(1):81-99. [6] Hearing VJ.Biochemical control of melanogenesis and melanosomal organization.J Investig Dermatol Symp Proc,1999,4(1):24-28. [7] Le Poole IC,Mutis T,van den Wijngaard RM,et al.A novel,antigenpresenting function of melanocytes and its possible relationship to hypopigmentary disorders.J Immunol,1993,151(12):7284-7292. [8] Le Poole IC,van den Wijngaard RM,Westerhof W,et al.Phagocytosis by normal human melanocytes in vitro.Exp Cell Res,1993,205(2):388-395. [9] McCoy KD,Le Gros G.The role of CTLA-4 in the regulation of T cell immune responses.Immunol Cell Biol,1999,77(1):i-10. [10] Kemp EH,Ajjan RA,Waterman EA,et al.Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo.Br J Dermatol,1999,140(1):73-78. [11] Overwijk WW,Lee DS,Surman DR,et al.Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice:requirement for CD4(+) T lymphocytes.Proc Natl Acad Sci USA,1999,96(6):2982-2987. [12] Gilhar A,Zelickson B,Ulman Y,et al.In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo.J Invest Dermatol,1995,105(5):683-686. [13] van den Wijngaard R,Wankowicz-Kalinska A,Le Poole C,et al.Local immune response in skin of generalized vitiligo patients.Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site.Lab Invest,2000,80(8):1299-1309. [14] Rivoltini L,Badrizzani M,Accomero P,et al.Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.J Immunol,1998,161(3):1220-1230. [15] Rosenberg SA.Cancer vaccines based on the identification of genes encoding cancer regression antigens.Immunol Today,1997,18(4):175-182. [16] Ogg GS,Rod Dunbar P,Romero P,et al.High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo.J Exp Med,1998,188(6):1203-1208. [17] Pittet MJ,Valmori D,Dunbar PR,et al.High frequencies of naive MelanA/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen(HLA)-A2 individuals.J Exp Med,1999,190(5):705-715. [18] Yee C,Thompson JA,Roche P,et al.Melanocyte destruction after antigen-specific immunotherapy of melanoma:direct evidence of t cell-mediated vitiligo.J Exp Med,2000,192(11):1637-1644. [19] Zarour HM,Kirkwood JM,Kierstead LS,et al.Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-reatricted epitope recognized by melanoma-reactive CD4+T cells.Proc Natl Acad Sci U S A,2000,97(1):400-405. [20] Das PK,van den Wijngaard RM,Wankowicz-Kalinska A,et al.A symbiotic concept of autoimmunity and tumour immunity:lessons from vitiligo.Trends Immunol,2001,22(3):130-136. [21] Wang S,Bartido S,Yang G,et al.A role for a melanosome transport sigral in accessing the MHC class Ⅱ presentation pathway and in eliciting CD4+T cell responses.J Immunol,1999,163(11):5820-5826. [22] Krutmann J,Morita A.Mechanisms of ultraviolet(UV) B and UVA phototherapy.J Investig Dermatol Symp Proc,1999,4(1):70-72. |
|
|
|
通讯作者: |
|